Variation in gene expression patterns in follicular lymphoma and the response to rituximab.
about
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsA new Fc receptor homolog, FREB2, found in germinal center B cellsOn the epistemological crisis in genomicsReuse of imputed data in microarray analysis increases imputation efficiencyInfluence of microarrays experiments missing values on the stability of gene groups by hierarchical clusteringGenome-scale identification of membrane-associated human mRNAs.Molecular diagnosis of orbital inflammatory diseaseAn integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinomaA pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administrationMulticolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome.Analysis of pharmacokinetics, pharmacodynamics, and pharmacogenomics data sets using VizStruct, a novel multidimensional visualization technique.Quantifying stability in gene list ranking across microarray derived clinical biomarkers.DATE analysis: A general theory of biological change applied to microarray data.Comparative analysis of missing value imputation methods to improve clustering and interpretation of microarray experiments.Missing value imputation for microarray data: a comprehensive comparison study and a web tool.Shrinkage regression-based methods for microarray missing value imputation.Follicular lymphoma: still Six characters in search of an author?Building gene expression profile classifiers with a simple and efficient rejection option in R.CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.Host genetics in follicular lymphomaRisk Factors of Non-Hodgkin LymphomaGene expression profiling and its application in studies of haematological malignancy.Predicting disease using genomics.Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.Genomic perspective and cancer.DNA-microarray analysis of brain cancer: molecular classification for therapy.A perspective on DNA microarrays in pathology research and practiceOrbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling.Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.Rituximab therapy in malignant lymphoma.High-sensitivity detection methods for low-abundance RNA species: applications for functional genomics research.Molecular diagnosis: Implications for ophthalmology.Molecular signatures of obstructive sleep apnea in adults: a review and perspective.Antibodies against G-protein coupled receptors: novel uses in screening and drug development.Biology and treatment of follicular lymphoma.Modulation of tumor immunity by therapeutic monoclonal antibodies.The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumAntibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo.Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies.
P2860
Q21562666-9440E06F-972D-4A83-A5CC-A25ED0BE0E65Q24299722-0D0DDD2B-7DEA-4704-982B-938A840F6251Q24652735-91F410E0-EA70-40F5-BED6-B74AC881CEF3Q24794335-D25D627D-70E4-44F5-B51E-5B775C37019CQ24803133-DA940286-32FA-47CF-84C3-20A5CBF7C71CQ25256725-315A6061-F940-42F5-97F1-9A5FE216DCAAQ27302778-87CAF7E1-9A2C-47F2-89A0-C0F686BB4B10Q28237169-EE1CCDF7-23C0-448C-8927-BA49AB743EF0Q28571862-B9CD9C12-BA65-4535-A383-AB9545901A65Q30819544-A7F68434-7754-4619-A60E-D4BCB1514E58Q30936719-102775D9-F96C-4359-BD3F-5844EA159AACQ31034756-21F70A28-2C9B-4A17-B7A5-F8A00806E5DDQ33494114-53009F06-B7F6-4E86-B605-46F036752740Q33522479-F773C803-40C2-4926-90B0-696A73AB5F7EQ33640883-2D643881-D7BC-4A1B-B662-D9EB8F9E4D8DQ33641285-A802D402-D779-4D3C-BEB9-780C1476FC81Q33927978-C4584F32-A1D2-4BAC-803D-7D24353AEA24Q34176222-A816A253-74D9-4FE8-A798-72944D2F7260Q34688644-DE6214EE-D750-4F45-BB59-0D3C347B455EQ35038312-3C817CFF-6EEC-40A4-97CE-8ACBDE8DE7E0Q35499320-D4D3DB73-1876-45B8-8622-CCD13F707BC3Q35661018-7E5DA37C-E8CC-417C-8DAF-BAA20121F928Q35784521-B9D8C722-285C-43AF-913F-6E7D777C6E40Q35839898-93F7E5FD-D426-4ED2-AA8B-31ABA3389CB2Q35875188-41EC858D-52CD-4BF4-A8D0-983FA8605ED2Q35892040-5A0BD088-8BD9-4C37-B930-5B419459DF4CQ35916012-F0523679-566E-4547-B4A8-8AB70CD8503DQ36113515-E50A58BC-5ADF-47F2-917F-42A3DECAB76BQ36429463-680E83D0-1B0C-4199-A09D-C5DB475BD9E4Q36713498-843B6513-2F9B-4F41-A9C1-A4F742E50AA3Q36832102-8B25C550-FF44-4BE2-905B-6D3FFD680D83Q37004625-25FDE2C4-920F-49EF-9489-199998200E55Q37018285-BFAE065C-A482-49D7-A17C-0E4F16010B08Q37146506-AD8C9F68-B6E3-4C89-9E1B-E1E71DEB3EEBQ37233054-1528F54D-F2D5-42CA-A11F-EC9C63E81816Q37810118-3C30EB7A-E116-4DFA-9699-679EE7BEEADBQ37832438-CE0F1B31-E5C4-48DD-86B1-8BF63C5D2667Q38572605-1E8584E1-8854-431D-85D6-0D08CF8C2CE1Q40166731-359B760A-A88F-4B0D-9DF1-FABD944FE813Q40641957-D507F468-3546-4646-A1F3-6A6C76C0B550
P2860
Variation in gene expression patterns in follicular lymphoma and the response to rituximab.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Variation in gene expression p ...... and the response to rituximab.
@ast
Variation in gene expression p ...... and the response to rituximab.
@en
Variation in gene expression p ...... and the response to rituximab.
@nl
type
label
Variation in gene expression p ...... and the response to rituximab.
@ast
Variation in gene expression p ...... and the response to rituximab.
@en
Variation in gene expression p ...... and the response to rituximab.
@nl
prefLabel
Variation in gene expression p ...... and the response to rituximab.
@ast
Variation in gene expression p ...... and the response to rituximab.
@en
Variation in gene expression p ...... and the response to rituximab.
@nl
P2093
P2860
P50
P356
P1476
Variation in gene expression p ...... and the response to rituximab.
@en
P2093
Orly Alter
Roger Warnke
Ronald Levy
Sean P Bohen
P2860
P304
P356
10.1073/PNAS.0437875100
P407
P577
2003-02-05T00:00:00Z